Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	2,510	2,355	1,887	1,489	1,134	1,046
Revenue Growth (YoY)	18.42%	24.81%	26.76%	31.34%	8.38%	32.71%
Cost of Revenue	925.9	765.1	604.7	487	342.4	285.1
Gross Profit	1,584	1,590	1,282	1,002	791.1	760.8
Selling, General & Admin	1,085	1,007	887.6	752.7	583.3	433.3
Operating Expenses	1,085	1,007	887.6	752.7	583.3	433.3
Operating Income	499.1	583	394.8	249	207.8	327.5
Interest Expense	-	-	-	-	-25.8	-32.8
Interest & Investment Income	88.2	91	52.8	4.1	3.8	12.6
EBT Excluding Unusual Items	587.3	674	447.6	253.1	185.8	307.3
Gain (Loss) on Sale of Investments	-56.1	-37.1	28.4	30.8	20.9	-17.7
Other Unusual Items	-	-138.4	-	-70	-	-18.4
Pretax Income	527.1	486	332.1	213.9	101.4	106.7
Income Tax Expense	178.8	144.7	82.4	59.4	11.8	-300.6
Net Income	348.3	341.3	249.7	154.5	89.6	407.3
Net Income to Common	348.3	341.3	249.7	154.5	89.6	407.3
Net Income Growth	2.68%	36.68%	61.62%	72.43%	-78.00%	1000.81%
Shares Outstanding (Basic)	100	100	98	96	95	93
Shares Outstanding (Diluted)	103	104	101	99	98	98
Shares Change (YoY)	-0.05%	2.67%	2.12%	1.02%	0.10%	2.19%
EPS (Basic)	3.49	3.40	2.56	1.61	0.95	4.37
EPS (Diluted)	3.39	3.29	2.47	1.56	0.92	4.16
EPS Growth	2.97%	33.20%	58.33%	69.56%	-77.89%	966.67%
Free Cash Flow	528.7	557.2	361.6	322.9	233.1	217.6
Free Cash Flow Per Share	5.15	5.37	3.58	3.27	2.38	2.23
Gross Margin	63.11%	67.52%	67.96%	67.29%	69.79%	72.74%
Operating Margin	19.89%	24.75%	20.92%	16.73%	18.33%	31.31%
Profit Margin	13.88%	14.49%	13.23%	10.38%	7.90%	38.94%
Free Cash Flow Margin	21.07%	23.66%	19.16%	21.69%	20.57%	20.80%
EBITDA	527.6	610.1	416.1	264.6	218.7	336.1
EBITDA Margin	21.02%	25.90%	22.05%	17.77%	19.29%	32.14%
D&A For EBITDA	28.5	27.1	21.3	15.6	10.9	8.6
EBIT	499.1	583	394.8	249	207.8	327.5
EBIT Margin	19.89%	24.75%	20.92%	16.73%	18.33%	31.31%
Effective Tax Rate	33.92%	29.77%	24.81%	27.77%	11.64%	-
Revenue as Reported	2,510	2,355	1,887	1,489	1,134	1,046
Advertising Expenses	-	191	159.9	149.7	139.8	64.8

Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q